A retrospective comparison of rituximab vs cyclophosphamide in neuromyelitis optica spectrum disorders patients

被引:0
|
作者
Radaelli, M. [1 ]
Pensato, U. [1 ]
Sangalli, F. [1 ]
Moiola, L. [1 ]
Esposito, F. [1 ]
Greco, G. [1 ]
Colombo, B. [1 ]
Comola, M. [1 ]
Comi, G. [1 ]
Martinelli, V. [1 ]
机构
[1] Ist Sci San Raffaele, Milan, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P844
引用
收藏
页码:434 / 435
页数:2
相关论文
共 50 条
  • [31] VOIDING DYSFUNCTION IN PATIENTS WITH NEUROMYELITIS OPTICA SPECTRUM DISORDERS
    Gomes, Cristiano
    Carvalho, Fabricio
    Bissoli, Julio
    Bessa, Jose, Jr.
    Pereira, Samira
    Marchioli, Paulo
    Callegaro, Dagoberto
    Bruschini, Homero
    Srougi, Miguel
    NEUROUROLOGY AND URODYNAMICS, 2011, 30 (02) : 253 - 254
  • [32] Clinical and biochemical evaluation of rituximab as add on therapy in neuromyelitis optica spectrum disorders
    Ding, Chawen
    Zheng, Lei
    Xiong, Mingjian
    Zhang, Dongping
    Chen, Zhongmei
    Wang, Linge
    Luo, Zhihua
    Qiao, Hong
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024,
  • [33] VOIDING DYSFUNCTION IN PATIENTS WITH NEUROMYELITIS OPTICA SPECTRUM DISORDERS
    Carvalho, Fabricio
    Gomes, Cristiano
    Pereira, Samira
    Bessa, Jose
    Bissoli, Julio, Jr.
    Callegaro, Dagoberto
    Marchiori, Paulo
    Bruschini, Homero
    Srougi, Miguel
    JOURNAL OF UROLOGY, 2011, 185 (04): : E605 - E605
  • [34] Rituximab in Neuromyelitis Optica Spectrum Disorders: Why Not as First-Line Therapy
    Kim, Su-Hyun
    Kim, Ho Jin
    JAMA NEUROLOGY, 2017, 74 (04) : 482 - 482
  • [35] A meta-analysis on efficacy and safety of rituximab for neuromyelitis optica spectrum disorders
    Dong, Gu-Yi
    Meng, Yan-Hong
    Xiao, Xiang-Jian
    MEDICINE, 2022, 101 (36) : E30347
  • [36] Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders
    Carreon Guarnizo, E.
    Hernandez Clares, R.
    Castillo Trivino, T.
    Meca Lallana, V
    Arocas Casan, V
    Iniesta Martinez, F.
    Olascoaga Urtaza, J.
    Meca Lallana, J. E.
    NEUROLOGIA, 2022, 37 (03): : 178 - 183
  • [37] Voiding Dysfunction in Patients With Neuromyelitis Optica Spectrum Disorders
    de Carvalho, Fabricio Leite
    Gomes, Cristiano Mendes
    Apostolos-Pereira, Samira L.
    Bessa, Jose, Jr.
    Pinheiro, Marcello
    Marchiori, Paulo E.
    Bruschini, Homero
    Srougi, Miguel
    Callegaro, Dagoberto
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 (01) : 39 - 43
  • [38] Autonomic Dysfunction in Patients with Neuromyelitis Optica Spectrum Disorders
    Kwon, Soonwook
    Kim, Ye Sel
    Kim, Juhyeon
    Seok, Jin Myoung
    Jung, Yun Shin
    Kim, Byoung Joon
    Min, Ju-Hong
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 478 - 478
  • [39] Screening for neuromyelitis optica and the neuromyelitis optica- spectrum disorders in Greek patients with demyelinating disease
    Evangelopoulos, M. -E.
    Andreadou, E.
    Koutsis, G.
    Dimitrakopoulos, A.
    Karantoni, E.
    Logiotatos, N.
    Alexakis, T.
    Vassilopoulos, D.
    Sfagos, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 254 - 254
  • [40] Prognostic factors in a cohort of neuromyelitis optica and neuromyelitis optica spectrum disorders
    Orviz-Garcia, A.
    Gonzalez-Suarez, I.
    Matias-Guiu, J.
    Oreja-Guevara, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 375 - 375